Innovation in precision pathogen control
Bacteriophages—naturally occurring viruses that eliminate specific bacteria—are highly specific tools for controlling targeted bacteria without promoting antimicrobial resistance while preserving a healthy microbiome.
Naturally safe for birds and consumers, bacteriophages are precision solutions to combat the losses caused by major poultry pathogens like Salmonella and pathogenic E. coli, driving better animal performance and safeguarding food safety. As antimicrobial resistance becomes a critical global threat, bacteriophages align perfectly with the growing demand for responsible use of antibiotics and support the worldwide fight against resistant bacteria.
In poultry production, bacteriophages offer a sustainable path to maintain animal performance, lower foodborne disease risks and enhance farm profitability—making them one of the most promising tools for the industry’s future.
Responding to the needs of our customers
Leveraging better pathogen control into performance
Avian pathogenic E. coli (APEC) compromises broiler flock health, increasing mortality and reducing zootechnical performance. Large genetic diversity and high prevalence of multi-drug resistance present challenging conditions for conventional solutions. Thanks to their broad-spectrum approach, Phileo bacteriophage solutions can target these pathogens with formidable efficacy, supporting health management programs alongside preventive solutions and antibiotics. In field trials conducted in commercial production units, flocks which received Phileo bacteriophage solutions for the control of APEC showed a noticeable reduction in bird mortality, enabling producers to unlock the full productive potential of their flocks.
Strengthening food safety
Salmonella contamination represents a major risk of foodborne illness. By reducing Salmonella across a broad spectrum of serovars in the bird digestive tract, Phileo bacteriophage solutions help decrease the risk of contamination of carcasses at the farm gate. This directly supports regulatory compliance and strengthens consumer confidence in poultry meat safety. Optimized to the relevant serovars circulating in the poultry industry thanks to our technological platform, the Phileo bacteriophage portfolio adapts to the future evolution of Salmonella pressure.
Building trust through transparency and adaptability
Our Pathogen Surveillance Program offers complete transparency by regularly monitoring, on our customers’ farms, the susceptibility of bacteria to our solutions. This continuous surveillance enables rapid detection of emerging new strains. Through our advanced technological platform, we quickly adapt our solutions to epidemiological shifts, ensuring Phileo bacteriophage solutions remain reliable and trusted in the long term. This commitment to continuous improvement guarantees sustained value for our customers cycle after cycle.
An alliance forged with phages
With a legacy of avant-garde microbial solutions and programs for animal health and nutrition, Phileo believes in the potential of bacteriophage solutions and has the ambition to develop the most advanced phage portfolio to better serve customer needs.
Partnering with PhageLab, an undisputed expert in bacteriophage solutions for animal health with advanced technologies, we combine complementary expertise and ambitions.
PhageLab brings 17 years of scientific expertise in bacteriophage research, development and industrial-scale production, scientifically proven from lab to field and validated through multiple market authorizations in major markets. As the most promising company in phage applications for poultry, PhageLab has established itself as a trusted partner for major poultry integrators, with solutions already adopted in millions of birds globally.
Our shared ambition: accelerating the adoption of science-based bacteriophage solutions globally to protect poultry and safeguard consumers.
Next Phage Intelligence
Behind Phileo bacteriophage solutions lies rigorous science. An advanced research and development platform combines genomics, microbiology and artificial intelligence to understand the diversity of pathogens, find the right bacteriophages and develop cocktails with precision and purpose.
Phileo bacteriophage solutions are designed following a proprietary, patented approach that combines in silico and in vitro research with AI technology, ensuring that each cocktail combination is optimized for broad-spectrum efficacy, powerful activity and consistent performance cycle after cycle.
This scientific rigor is validated through peer-reviewed publications and field efficacy studies conducted in commercial production units, backed by the long-lasting trust of our customers.
Sustained protection through long-term surveillance
The performance of Phileo bacteriophage solutions is continuously monitored in the field. Through our global Pathogen Surveillance Program, we regularly sample and test bacterial populations on our customers’ farms to track the performance of the deployed solutions under their specific conditions and detect the emergence of new or more prevalent bacterial strains.
This real-time monitoring ensures consistent performance cycle after cycle, guaranteeing a sustained impact on animal performance and reducing the risks of foodborne disease. Recognizing that new pathogenic challenges can emerge, our advanced platform enables rapid solution adaptation, securing long-term efficacy and protecting farm profitability.
The information provided on this website is to the best of our knowledge, true and accurate. Not all products are available in all regions nor are the associated intended uses and/or claims the same in all regions. Products must only be used in compliance with local laws and regulations and we cannot guarantee freedom for every intended use or country.
Subscribe to
our Newsletter
